AREC — Arecor Therapeutics Share News
0.000.00%
- £16.42m
- £13.40m
- £5.05m
REG - Arecor Therapeutics - Result of AGM
AnnouncementREG - Arecor Therapeutics - Non-Executive Director Board Change
AnnouncementREG - Arecor Therapeutics - Director/PDMR Dealing
AnnouncementREG - Arecor Therapeutics - Arecor Partnership with Skye Bioscience
AnnouncementREG - Arecor Therapeutics - Director Dealing
AnnouncementREG - Arecor Therapeutics - Arecor sells rights to non-Ogluo® products
AnnouncementREG - Arecor Therapeutics - Posting of 2024 Annual Report and Notice of AGM
AnnouncementRCS - Arecor Therapeutics - Arecor to present on Investor Meet Company
AnnouncementREG - Arecor Therapeutics - Grant of Options and PDMR Dealing
AnnouncementREG - Arecor Therapeutics - Final results for 2024
AnnouncementREG - Arecor Therapeutics - Notice of Results
AnnouncementREG - Arecor Therapeutics - Collaboration with global pharmaceutical partner
AnnouncementREG - Arecor Therapeutics - Arecor partnership with biopharmaceutical company
AnnouncementREG - Arecor Therapeutics - Arecor Full Year 2024 Trading Update
AnnouncementREG - Arecor Therapeutics - Orderly Cessation of Tetris Pharma Operations
AnnouncementREG - Arecor Therapeutics - Change of Nominated Advisor and Joint Broker
AnnouncementREG - Arecor Therapeutics - Arecor Signs Exclusive Licensing Agreement
AnnouncementREG - Arecor Therapeutics - Grant of Options and PDMR Dealing
AnnouncementREG - Arecor Therapeutics - Arecor Appoints Interim Chief Financial Officer
Announcement